4//SEC Filing
NOVEN PHARMACEUTICALS INC 4
Accession 0001209191-06-059086
CIK 0000815838operating
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:40 PM ET
Size
14.4 KB
Accession
0001209191-06-059086
Insider Transaction Report
Form 4
MANTELLE JUAN A
VP and Chief Technical Officer
Transactions
- Exercise/Conversion
Common Stock ($.0001 par value)
2006-11-08$10.45/sh+29,999$313,490→ 36,699 total - Sale
Common Stock ($.0001 par value)
2006-11-08$22.88/sh−40,000$915,020→ 6,700 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-11-08−29,999→ 20,001 totalExercise: $10.45Exp: 2010-11-04→ Common Stock ($.0001 par value) (29,999 underlying) - Sale
Common Stock ($.0001 par value)
2006-11-08$22.88/sh−29,999$686,242→ 6,700 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-11-08−40,000→ 10,000 totalExercise: $13.11Exp: 2009-09-04→ Common Stock ($.0001 par value) (40,000 underlying) - Exercise/Conversion
Common Stock ($.0001 par value)
2006-11-08$13.11/sh+40,000$524,400→ 46,700 total
Footnotes (2)
- [F1]20% exercisable after 11/05/2004; 20% exercisable after 11/05/2005; 20% exercisable after 11/05/2006; 20% exercisable after 11/05/2007; 20% exercisable after 11/05/2008.
- [F2]20% exercisable after 09/05/2003; 20% exercisable after 09/05/2004; 20% exercisable after 09/05/2005; 20% exercisable after 09/05/2006; 20% exercisable after 09/05/2007.
Documents
Issuer
NOVEN PHARMACEUTICALS INC
CIK 0000815838
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000815838
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:40 PM ET
- Size
- 14.4 KB